BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 16827646)

  • 1. Diagnosis and monitoring of human cytomegalovirus infection in bone marrow transplant recipients by quantitative competitive PCR.
    Ziyaeyan M; Sabahi F; Alborzi A; Mahboudi F; Kazemnejad A; Ramzi M; Moravej A; Jaberi MM
    Exp Clin Transplant; 2006 Jun; 4(1):470-4. PubMed ID: 16827646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qualitative detection of human cytomegalovirus DNA in the plasma of bone marrow transplant recipients: value as a predictor of disease progression.
    Behzad-Behbahani A; Ehsanipour F; Alborzi A; Nourani H; Ramzi M; Rasoli M
    Exp Clin Transplant; 2004 Jun; 2(1):196-200. PubMed ID: 15859928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of human cytomegalovirus DNA by a new capture hybrid polymerase chain reaction enzyme-linked immunosorbent assay in plasma and peripheral blood mononuclear cells of bone marrow transplant recipients.
    Ziyaeyan M; Sabahi F; Alborzi A; Ramzi M; Mahboudi F; Pourabbas B; Kadivar M
    Exp Clin Transplant; 2008 Dec; 6(4):294-300. PubMed ID: 19338492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of a double primer PCR assay with plasma, leukocytes and antigenemia for diagnosis of active human cytomegalovirus infection in bone marrow transplant patients.
    Yaghobi R; Behzad-Behbahani A; Sabahi F; Roustaee MH; Alborzi A; Ramzi M; Nourani H
    Bone Marrow Transplant; 2005 Mar; 35(6):595-9. PubMed ID: 15665849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abortive human cytomegalovirus infection in patients after allogeneic bone marrow transplantation.
    de Gast GC; Boland GJ; Vlieger AM; de Weger RA; Verdonck LF; Zwaan FE; Jiwa NM
    Bone Marrow Transplant; 1992 Apr; 9(4):221-5. PubMed ID: 1318140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic significance and clinical impact of quantitative assays for diagnosis of human cytomegalovirus infection/disease in immunocompromised patients.
    Gerna G; Percivalle E; Baldanti F; Sarasini A; Zavattoni M; Furione M; Torsellini M; Revello MG
    New Microbiol; 1998 Jul; 21(3):293-308. PubMed ID: 9699213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the NucliSens CMV pp67 assay for detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation.
    Hebart H; Rudolph T; Loeffler J; Middeldorp J; Ljubicic T; Jahn G; Einsele H
    Bone Marrow Transplant; 2002 Aug; 30(3):181-7. PubMed ID: 12189537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of antigenemia assay and semiquantitative polymerase chain reaction test for monitoring active cytomegalovirus infection in allogeneic hematopoietic cell transplant recipients.
    Pajand O; Ziyaeyan M; Mousavi S; Fatolahzadeh B; Hojabri Z; Bahador A; Abdossamadi Z
    Exp Clin Transplant; 2008 Jun; 6(2):149-54. PubMed ID: 18816243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Direct detection of human cytomegalovirus in urine specimens from bone marrow transplant patients by polymerase chain reaction].
    Ohshima T; Miyachi H; Fusegawa H; Tanaka S; Yabe H; Yabe M; Kato S; Ando Y
    Rinsho Byori; 1996 Mar; 44(3):267-73. PubMed ID: 8857170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up of 28 HCMV seropositive renal-transplant recipients: comparison of clinical, biological and virological parameters in the groups of treated versus untreated infected patients.
    Kamar N; Mengelle C; Yahyaoui S; Sandres-Sauné K; Durand D; Izopet J; Rostaing L
    J Clin Virol; 2005 May; 33(1):35-42. PubMed ID: 15797363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiplex polymerase chain reaction for the evaluation of cytomegalovirus DNA load in organ transplant recipients.
    Nazzari C; Gaeta A; Lazzarini M; Castelli TD; Mancini C
    J Med Virol; 2000 Jun; 61(2):251-8. PubMed ID: 10797382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of HCMV DNA load in whole blood of renal transplant patients using real-time PCR assay.
    Gouarin S; Vabret A; Gault E; Petitjean J; Regeasse A; Hurault de Ligny B; Freymuth F
    J Clin Virol; 2004 Mar; 29(3):194-201. PubMed ID: 14962789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease.
    Gor D; Sabin C; Prentice HG; Vyas N; Man S; Griffiths PD; Emery VC
    Bone Marrow Transplant; 1998 Mar; 21(6):597-605. PubMed ID: 9543064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay, the amplicor CMV test, and a semi-quantitative polymerase chain reaction test after allogeneic marrow transplantation.
    Ksouri H; Eljed H; Greco A; Lakhal A; Torjman L; Abdelkefi A; Ben Othmen T; Ladeb S; Slim A; Zouari B; Abdeladhim A; Ben Hassen A
    Transpl Infect Dis; 2007 Mar; 9(1):16-21. PubMed ID: 17313466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of PCR serum in diagnosing and monitoring cytomegalovirus reactivation in bone marrow transplant recipients.
    Matsunaga T; Sakamaki S; Ishigaki S; Kohda K; Takeda M; Katoh J; Kuroda H; Hirayama Y; Kusakabe T; Akiyama T; Kuga T; Niitsu Y; Masaoka T; Sagawa T; Matsumoto Y
    Int J Hematol; 1999 Feb; 69(2):105-11. PubMed ID: 10071460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time of onset, viral load, relapse, and duration of active cytomegalovirus infection in bone marrow transplant outcomes.
    Habib K; Lamia T; Amel L; Abdelrahmen A; Saloua L; Hana E; Amine S; Bechir Z; Tarek BO; Assia BH
    Exp Clin Transplant; 2008 Mar; 6(1):67-73. PubMed ID: 18405248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the COBAS Amplicor HCMV Monitor for early detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation.
    Lengerke C; Ljubicic T; Meisner C; Loeffler J; Sinzger C; Einsele H; Hebart H
    Bone Marrow Transplant; 2006 Jul; 38(1):53-60. PubMed ID: 16788683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole blood real-time quantitative PCR for cytomegalovirus infection follow-up in transplant recipients.
    Garrigue I; Boucher S; Couzi L; Caumont A; Dromer C; Neau-Cransac M; Tabrizi R; Schrive MH; Fleury H; Lafon ME
    J Clin Virol; 2006 May; 36(1):72-5. PubMed ID: 16481215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of human cytomegalovirus in recipients of solid organ transplants by real-time quantitative PCR and pp65 antigenemia.
    Mengelle C; Pasquier C; Rostaing L; Sandres-Sauné K; Puel J; Berges L; Righi L; Bouquies C; Izopet J
    J Med Virol; 2003 Feb; 69(2):225-31. PubMed ID: 12683412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
    Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
    Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.